My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes.

    Heinemann L, Nosek L, Kapitza C, Schweitzer MA, Krinelke L.

    Diabetes Care. 2009 Aug;32(8):1437-9. Epub 2009 Jun 1.PMID: 19487635 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.

    Bevier WC, Zisser H, Palerm CC, Finan DA, Seborg DE, Doyle FJ, Wollitzer AO, Jovanovic L.

    Diabetes Metab Res Rev. 2007 Sep;23(6):472-8.PMID: 17315240 [PubMed - indexed for MEDLINE]Related articles

    3.

    Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.

    Horvath K, Bock G, Regittnig W, Bodenlenz M, Wutte A, Plank J, Magnes C, Sinner F, Fürst-Recktenwald S, Theobald K, Pieber TR.

    Diabetes Obes Metab. 2008 Jun;10(6):484-91. Epub 2007 Aug 30.PMID: 17764465 [PubMed - indexed for MEDLINE]Related articles

    4.

    Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients.

    Bruttomesso D, Fongher C, Silvestri B, Barberio S, Marescotti MC, Iori E, Valerio A, Crazzolara D, Pianta A, Tiengo A, Del Prato S.

    Diabetes Res Clin Pract. 2001 Feb;51(2):97-105.PMID: 11165689 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

    Diabetes Care. 1995 Nov;18(11):1452-9.PMID: 8722069 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

    Attia N, Jones TW, Holcombe J, Tamborlane WV.

    Diabetes Care. 1998 May;21(5):817-21.PMID: 9589247 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

    Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.

    Clin Ther. 2009 May;31(5):980-7.PMID: 19539098 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in type 1 (insulin-dependent) diabetic patients.

    Robert JJ, Chauvet D, Darmaun D, Leblanc H.

    Diabetologia. 1993 Nov;36(11):1185-90.PMID: 8270134 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

    Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Characterization of the insulin-antagonistic effect of growth hormone in insulin-dependent diabetes mellitus.

    Fowelin J, Attvall S, von Schenck H, Smith U, Lager I.

    Diabet Med. 1995 Nov;12(11):990-6.PMID: 8582132 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insulin detemir under steady-state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes.

    Bott S, Tusek C, Jacobsen LV, Endahl L, Draeger E, Kapitza C, Heise T.

    Diabet Med. 2006 May;23(5):522-8.PMID: 16681561 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

    Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

    Diabetes Care. 1993 Oct;16(10):1347-55.PMID: 8269792 [PubMed - indexed for MEDLINE]Related articles

    13.

    Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.

    Bartolo PD, Pellicano F, Scaramuzza A, Sardu C, Casetti T, Bosi E, Miselli V, Brandolini S, Fabbri T, Meandri P, Cannatà F.

    Diabetes Technol Ther. 2008 Dec;10(6):495-8.PMID: 19049379 [PubMed - indexed for MEDLINE]Related articles

    14.

    An unbiased glucose clamp method using a variable insulin infusion: its application in diabetic adolescents.

    Matthews DR, Edge JA, Dunger DB.

    Diabet Med. 1990 Mar-Apr;7(3):246-51.PMID: 2139397 [PubMed - indexed for MEDLINE]Related articles

    15.

    Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

    Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

    Diabetes. 2002 Oct;51(10):3043-8.PMID: 12351445 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?

    Staehr P, Hojlund K, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

    Diabet Med. 2003 Oct;20(10):816-22.PMID: 14510862 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.

    Guerci B, Meyer L, Sallé A, Charrié A, Dousset B, Ziegler O, Drouin P.

    J Clin Endocrinol Metab. 1999 Aug;84(8):2673-8.PMID: 10443658 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study.

    Catargi B, Meyer L, Melki V, Renard E, Jeandidier N; for the EVADIAC Study Group.

    Diabetes Metab. 2002 Apr;28(2):133-7.PMID: 11976565 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Symptoms, hormones, and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in Type I diabetes.

    Selam JL, Medlej R, M'bemba J, Chevalier A, Guyon F, Ashworth L, Slama G.

    Diabet Med. 1995 Dec;12(12):1102-9.PMID: 8750221 [PubMed - indexed for MEDLINE]Related articles

    20.

    Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.

    Zisser HC, Bevier WC, Jovanovic L.

    Diabetes Technol Ther. 2007 Dec;9(6):509-15.PMID: 18034605 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity